Bcd Bioscience, A Precision Prebiotic Fiber Company, Raises $12M In Series A Funding To Develop Lead Products
Apr 14, 2022•over 3 years ago
Amount Raised
$12 Million
Round Type
series a
Description
BCD Bioscience, a biotechnology company creating precision prebiotics from natural fibers, today announced that it has completed an oversubscribed Series A financing round of $12 million led by Acre Venture Partners. Existing investors, Seventure Partners and iSelect Fund, upped their commitments for the round and new investors, Collaborative Fund and Skyviews Life Science, have joined.
FundzWatch™ Score
85
Medium Activity
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech